May 2022 Archive
8431.
An Infinitely Large Napkin v1.5 (web.evanchen.cc)
8432.
Logseq and the Rise of the Integrated Thinking Environment (blog.logseq.com)
8433.
Towards Gnome Shell on Mobile (blogs.gnome.org)
8434.
A Face Search Engine Anyone Can Use Is Alarmingly Accurate (nytimes.com)
8435.
Uroboros: lightweight high-level scripting language for files automation (uroboros-lang.org)
8436.
DuskOS (git.sr.ht)
8437.
Nvidia's Grace CPU to Power Two Supercomputers, Up to Ten 'AI ExaFlops' (tomshardware.com)
8438.
Tell HN: Android Kindle app doesn't allow in-app purchases anymore
8439.
GOP senators want to ban China’s digital currency from US apps and app stores (arstechnica.com)
8440.
SerpentOS (serpentos.com)
8441.
Top-Paid LA Lifeguards Earned Up to $510,283 in 2021 (openthebooks.substack.com)
8442.
US retakes first place from Japan on Top500 supercomputer ranking (engadget.com)
8443.
The Coming Food Catastrophe (youtube.com)
8444.
Murena, the privacy-first Android smartphone, arrives (zdnet.com)
8445.
Study gave at risk men therapy and money (vox.com)
8446.
A Bold Idea to Stall the Climate Crisis–By Building Better Trees (wired.co.uk)
8447.
Uncurled (un.curl.dev)
8448.
If money doesn’t make you happy then you probably aren’t spending it right(2011) [pdf] (aws1.discourse-cdn.com)
8449.
8450.
Amazon RDS now supports IPv6 (aws.amazon.com)
8451.
Add Mermaid to Hugo (bodunhu.com)
8452.
APL: An Array Oriented Programming Language (2018) (medium.com)
8453.
Musk told banks he will rein in Twitter pay, make money from tweets (reuters.com)
8454.
Entropy of city street networks linked to future spatial navigation ability (nature.com)
8455.
The Explosion of Cancer and Latent Disease (rumble.com)
8456.
Lessons from Russia's Occupation of a Ukrainian Village (theatlantic.com)
8457.
Proving the coding interview, part 2 (cs.utexas.edu)
8458.
Pseudo-Random Number Generation Using Generative Adversarial Networks (2018) (arxiv.org)
8459.
The Better Alternative to Lifetime GATs (sabrinajewson.org)
8460.
Moderna vaccine causes fewer people to develop anti-nucleocapsid antibodies (medrxiv.org)